Product
Help
Pricing
About
Jobs
Log in
Get started
Author
Add to collection
Daniela Arduini
Observed name:
Daniela ARDUINI
Institutions:
Università Cattolica del Sacro Cuore,
Agostino Gemelli University Polyclinic,
Istituti di Ricovero e Cura a Carattere Scientifico
Observed institutions:
Università Cattolica del Sacro Cuore,
Agostino Gemelli University Polyclinic,
Istituti di Ricovero e Cura a Carattere Scientifico
ORCID:
0000-0002-0624-9814
Observed ORCID:
0000-0002-0624-9814
OpenAlex ID:
A5084012523
Fecal microbiota transplantation plus pembrolizumab and axitinib in metastatic renal cell carcinoma: the randomized phase 2 TACITO trial
2026
·
Serena Porcari
, Chiara Ciccarese
, et al.
·
Nature Medicine
·
67
From magnesium to magnesium transporters in cancer: TRPM7, a novel signature in tumour development
2013
·
Valentina Trapani
, Daniela Arduini
, et al.
·
Magnesium Research
·
50
Dietary Magnesium Alleviates Experimental Murine Colitis Through Upregulation of the Transient Receptor Potential Melastatin 6 Channel
2018
·
Valentina Trapani
, Valentina Petito
, et al.
·
Inflammatory Bowel Diseases
·
43
Post nephrectomy management of localized renal cell carcinoma. From risk stratification to therapeutic evidence in an evolving clinical scenario
2023
·
Chiara Ciccarese
, Alessandro Strusi
, et al.
·
Cancer Treatment Reviews
·
42
PDF
Targeting hypoxia-inducible factor pathways in sporadic and Von Hippel-Lindau syndrome-related kidney cancers
2022
·
Roberto Iacovelli
, Daniela Arduini
, et al.
·
Critical Reviews in Oncology/Hematology
·
19
EGF stimulates Mg2+ influx in mammary epithelial cells
2014
·
Valentina Trapani
, Daniela Arduini
, et al.
·
Biochemical and Biophysical Research Communications
·
12
Magnesium Modulates Doxorubicin Activity through Drug Lysosomal Sequestration and Trafficking
2016
·
Valentina Trapani
, Francesca Luongo
, et al.
·
Chemical Research in Toxicology
·
6
Pattern of disease recurrence and outcomes after progression of high-risk renal cell carcinoma (RCC) patients treated with adjuvant immunotherapy
2026
·
Chiara Ciccarese
, Denis Occhipinti
, et al.
·
Cancer Immunology Immunotherapy
·
4
PDF
The Clinical Role of Hypoxia Inducible Factor (HIF) Inhibition in Renal Cancer: A Focus on Belzutifan
2025
·
Daniela Arduini
, Chiara Ciccarese
, et al.
·
Current Cancer Drug Targets
·
3
A phase II study of nivolumab plus metformin in pre-treated metastatic renal cell carcinoma patients: NivoMet TWINS-GU002 Study
2025
·
Chiara Ciccarese
, Daniela Arduini
, et al.
·
Tumori Journal
·
2
Patterns of first-line treatment selection in metastatic renal cell carcinoma: a real-world analysis from the Meet-URO 33—REGAL study
2026
·
Davide Bimbatti
, Cecilia Nasso
, et al.
·
Therapeutic Advances in Medical Oncology
·
1
Clinical and technical insights on KIM-1: what we need to know
2026
·
Daniela ARDUINI
, Antonio AGOSTINI
, et al.
·
Minerva Urology and Nephrology
·
1
2024 ASCO genitourinary cancers symposium: a focus on renal cell carcinoma
2024
·
Viria Beccia
, Daniela Arduini
, et al.
·
Expert Review of Anticancer Therapy
·
1
Emerging patterns of kidney cancer in young adults: where do we stand?
2026
·
Paola Troisi
, Denis Occhipinti
, et al.
·
Critical Reviews in Oncology/Hematology
The ITALIC-RCC: A Randomized Trial on Clinical and Humoral Impact of Primary Tumor Ablation by Surgery or Radiotherapy in Metastatic Renal Cell Carcinoma Treated with Checkpoint Inhibitors
2026
·
Roberto Iacovelli
, Chiara Ciccarese
, et al.
·
European Urology Open Science
PDF
The ITALIC-RCC study: A randomized study of clinical and humoral impact of primary tumor ablation in metastatic renal cell carcinoma treated with immunotherapy.
2026
·
Paola Troisi
, Chiara Ciccarese
, et al.
·
Journal of Clinical Oncology
Pattern of disease recurrence and outcomes of localized high-risk renal cell carcinoma (RCC) patients treated with adjuvant (adj) immunotherapy: A single center experience.
2026
·
Denis Occhipinti
, Chiara Ciccarese
, et al.
·
Journal of Clinical Oncology
PDF
Incidence and co-occurrence of targetable key genomic alterations (GenAlt) in metastatic prostate cancer (mPC): Preliminary results from the prostate cancer cohort of the FPG500 program.
2026
·
Daniela Arduini
, Chiara Ciccarese
, et al.
·
Journal of Clinical Oncology
PDF
Impact of immunotherapy in patients with upper tract urothelial carcinoma: a meta-analysis of randomized trials
2026
·
Denis Occhipinti
, CHIARA CICCARESE
, et al.
·
SSRN Electronic Journal
PDF
Updated results of the Tide-A study evaluating avelumab (Ave) plus intermittent axitinib (Axi) in previously untreated patients with metastatic renal cell carcinoma (mRCC).
2025
·
Daniela Arduini
, Chiara Ciccarese
, et al.
·
Journal of Clinical Oncology
Show more works
View as search
Works count:
20
Citation count:
251
H-index:
6
I10-index:
6
Year
Topic
Type